Opposing actions of endocannabinoids on cholangiocarcinoma growth: recruitment of Fas and Fas ligand to lipid rafts.
about
Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammationCannabinoids, endocannabinoids, and cancerMonoamine oxidase A expression is suppressed in human cholangiocarcinoma via coordinated epigenetic and IL-6-driven eventsCannabinoids as novel anti-inflammatory drugs.After damage of large bile ducts by gamma-aminobutyric acid, small ducts replenish the biliary tree by amplification of calcium-dependent signaling and de novo acquisition of large cholangiocyte phenotypes.Recent advances in the regulation of cholangiocarcinoma growthNeuronal CCL2 is upregulated during hepatic encephalopathy and contributes to microglia activation and neurological decline.Increasing antiproliferative properties of endocannabinoids in N1E-115 neuroblastoma cells through inhibition of their metabolism.Recent advances in the understanding of the role of the endocannabinoid system in liver diseases.Endocannabinoids and immune regulation.Caffeic acid phenethyl ester decreases cholangiocarcinoma growth by inhibition of NF-kappaB and induction of apoptosis.Neuropeptide Y inhibits cholangiocarcinoma cell growth and invasion.Knockout of the neurokinin-1 receptor reduces cholangiocyte proliferation in bile duct-ligated miceGonadotropin-releasing hormone stimulates biliary proliferation by paracrine/autocrine mechanismsMelatonin exerts by an autocrine loop antiproliferative effects in cholangiocarcinoma: its synthesis is reduced favoring cholangiocarcinoma growthThe therapeutic potential of orphan GPCRs, GPR35 and GPR55.Interleukin-6-driven progranulin expression increases cholangiocarcinoma growth by an Akt-dependent mechanismSuppression of the HPA axis during extrahepatic biliary obstruction induces cholangiocyte proliferation in the rat.Anti-proliferative effects of anandamide in human hepatocellular carcinoma cells.Suppression of the HPA Axis During Cholestasis Can Be Attributed to Hypothalamic Bile Acid Signaling.The novel growth factor, progranulin, stimulates mouse cholangiocyte proliferation via sirtuin-1-mediated inactivation of FOXO1.Bile Acid Signaling Is Involved in the Neurological Decline in a Murine Model of Acute Liver Failure.The potential relevance of the endocannabinoid, 2-arachidonoylglycerol, in diffuse large B-cell lymphoma.Serotonin metabolism is dysregulated in cholangiocarcinoma, which has implications for tumor growthOrphan G protein receptor GPR55 as an emerging target in cancer therapy and management.Wound healing and local neuroendocrine regulation in the injured liver.Mechanisms of biliary carcinogenesis and growthEndothelin inhibits cholangiocarcinoma growth by a decrease in the vascular endothelial growth factor expressionFollicle-stimulating hormone increases cholangiocyte proliferation by an autocrine mechanism via cAMP-dependent phosphorylation of ERK1/2 and Elk-1TGR5 signaling reduces neuroinflammation during hepatic encephalopathy.Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies?Changes in the endocannabinoid system may give insight into new and effective treatments for cancer.Update on the endocannabinoid system as an anticancer target.Receptor-dependent and receptor-independent endocannabinoid signaling: a therapeutic target for regulation of cancer growth.The Neuropeptide Galanin Is Up-Regulated during Cholestasis and Contributes to Cholangiocyte Proliferation.Lipid rafts and raft-mediated supramolecular entities in the regulation of CD95 death receptor apoptotic signaling.The evolving role of the endocannabinoid system in gynaecological cancer.Cannabinoids as Modulators of Cell Death: Clinical Applications and Future Directions.Anandamide oxidative metabolism-induced endoplasmic reticulum stress and apoptosis.miR-24 Inhibition Increases Menin Expression and Decreases Cholangiocarcinoma Proliferation.
P2860
Q24647850-42059A63-6DF3-45CB-940D-E8C3DDD36B87Q27694715-AB668D58-48E5-46DB-9645-11C0813141B4Q28273377-7E80C63B-C44B-41B4-A12B-DDB0E1DBA90CQ33688381-A087E59C-CA3F-4275-95D7-ADD8D8274B94Q33745195-6257D67E-2259-4BD9-BA72-43180AC2956FQ33994814-8C76564C-8CA6-42E6-9068-B9B23F4B0676Q34027245-00541C52-9311-40B4-BAED-1519093BBFAAQ34064728-3AF5D086-E114-437F-82CC-30C768BCA74DQ34550846-A1E6F0D1-18ED-42B2-8824-C75F2FFCC028Q34607419-57B6C111-BE40-4A2B-8100-118D84A6603EQ34636044-C79A0646-5F25-42C1-9B29-974CD724500EQ34979300-CED82A1F-3B84-489E-B422-6053ABC646C7Q35159620-CDCAE776-D96B-46B9-85B6-9E115E7AE9F8Q35236464-405704AB-3C35-4D85-85D3-2A1386E832DFQ35321923-465CEF71-072F-47CF-9BAD-AC05E4EBBD0EQ35425244-AFEEDD07-DEAA-483F-8EBD-1F0DE1C29A3DQ35841978-0AF11DD5-96B8-4A92-B183-E7BD3CD04216Q35939397-ACC2165B-93D6-4E3E-9D90-65EC2EBE7846Q36225947-704DEB9D-DEA5-49DF-B9F3-B9239608A35DQ36331780-C32B7017-9767-4D3B-BD68-3D286F26FED6Q36494373-2830B227-0753-4FB4-8FB2-ED34B563893CQ36509199-73A13C44-55A0-41C4-957D-A5E1CD923E29Q36575297-5E85A494-261F-4EDB-8B2B-81ABC1B9EECBQ36996185-0196759D-EE4A-4DCB-B867-D1D679AAF224Q36996563-8FED0682-5B34-4744-8982-2D401991E9D0Q37149500-151BED97-9172-4262-A245-06F5C19652C9Q37169351-53B9F4F7-546A-4D26-9133-7C9DA1050732Q37253350-5520818C-7D99-4CD7-B5E3-2A3BABC760A5Q37264501-8939CBFD-7652-489E-BB3E-75266784C9EDQ37272976-122A6C93-A77F-4B99-B7E6-CB0C1A13EE2DQ37546194-F8981251-EE3B-42AA-BFE2-5DC2FF3120EFQ37568679-8D03CD47-E390-4C93-885D-EE9928F29EA0Q37829751-5CC6FB68-C0B0-4E6D-A0C5-05CCE9ABDE93Q38052298-0C1A9EA1-CF41-4074-B1BA-A150533374ABQ38289054-37BE2056-922F-47BA-A165-EBB347A1D47AQ38363543-779394C1-B790-40A4-8882-E44ADAEEC084Q38469671-7B032650-4535-458C-AA20-CE5967708D64Q38692926-5262BBED-D7CA-4AA2-8EF5-3AC99580A620Q38715570-E420F5AB-665A-4C67-968F-B7D9BD2A8469Q38721397-85BC81C4-EF6C-4A87-BF65-5BE7D537DACB
P2860
Opposing actions of endocannabinoids on cholangiocarcinoma growth: recruitment of Fas and Fas ligand to lipid rafts.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Opposing actions of endocannab ...... and Fas ligand to lipid rafts.
@en
type
label
Opposing actions of endocannab ...... and Fas ligand to lipid rafts.
@en
prefLabel
Opposing actions of endocannab ...... and Fas ligand to lipid rafts.
@en
P2093
P2860
P356
P1476
Opposing actions of endocannab ...... and Fas ligand to lipid rafts.
@en
P2093
Bradley Vaculin
Gianfranco Alpini
Heather Francis
Julie Venter
Shannon Glaser
Sharon DeMorrow
Shelley Vaculin
P2860
P304
13098-13113
P356
10.1074/JBC.M608238200
P407
P577
2007-02-28T00:00:00Z